Sepideh Rahmati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sepideh Rahmati has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Kayvan Mirnia
Children’s Medical Hospital, Tehran University of Medical Science, Tehran, Iran
1 shared publication - Maryam Saeedi
Department of Neonatology Children’s Medical Center Pediatric Center of Excellence Tehran University of Medical Sciences Tehran Iran tums.ac.ir
1 shared publication - Parastoo Rostami
Children’s Medical Center, Tehran University of Medical Sciences 12 Division of Endocrinology and Metabolism, Department of Pediatrics Tehran
1 shared publication - Razieh Sangsari
Children’s Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Sedigheh Shams
Department of Clinical Biochemistry Children’s Medical Center Pediatric Center of Excellence Tehran University of Medical Sciences Tehran Iran tums.ac.ir
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1) , 9545724
Intracellular Cobalamin Defect in Early Infancy: A Cause of Hypotonia and Cytopenias
Intracellular cobalamin metabolism defects (ICMDs) are rare but inherited disorders that disrupt the conversion of cobalamin into its active cofactors, methylcobalamin and adenosylcobalamin. We report a 40‐day‐old female infant with progressive hypotonia, poor feeding, hydrocephalus, and pancytopenia, whose metabolic profile demonstrated severe hyperhomocysteinemia, elevated urinary methylmalonic acid, and low methionine despite normal serum vitamin B12. Bone marrow evaluation revealed profound hypercellularity with megaloblastic changes and hypersegmented neutrophils. These findings suggested an intracellular cobalamin defect, most consistent with the cblC subtype. Molecular analysis confirmed a homozygous frameshift mutation in the MMACHC gene, establishing the diagnosis of methylmalonic aciduria and homocystinuria, cblC type. Treatment with hydroxocobalamin, betaine, and folinic acid led to stabilization of hematologic parameters and significant clinical and biochemical improvement; however, it is important to recognize that therapy is not curative, and long‐term neurodevelopmental outcomes may remain guarded, especially in early‐onset cases.
- 1 January 2026
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1) , 9545724
Open AccessIntracellular Cobalamin Defect in Early Infancy: A Cause of Hypotonia and Cytopenias
Intracellular cobalamin metabolism defects (ICMDs) are rare but inherited disorders that disrupt the conversion of cobalamin into its active cofactors, methylcobalamin and adenosylcobalamin. We report a 40‐day‐old female infant with progressive hypotonia, poor feeding, hydrocephalus, and pancytopenia, whose metabolic profile demonstrated severe hyperhomocysteinemia, elevated urinary methylmalonic acid, and low methionine despite normal serum vitamin B12. Bone marrow evaluation revealed profound hypercellularity with megaloblastic changes and hypersegmented neutrophils. These findings suggested an intracellular cobalamin defect, most consistent with the cblC subtype. Molecular analysis confirmed a homozygous frameshift mutation in the MMACHC gene, establishing the diagnosis of methylmalonic aciduria and homocystinuria, cblC type. Treatment with hydroxocobalamin, betaine, and folinic acid led to stabilization of hematologic parameters and significant clinical and biochemical improvement; however, it is important to recognize that therapy is not curative, and long‐term neurodevelopmental outcomes may remain guarded, especially in early‐onset cases.